Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/17331
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWhitfield, Phillip D.en
dc.contributor.authorCalvin, J.en
dc.contributor.authorHogg, S.en
dc.contributor.authorO'Driscoll, E.en
dc.contributor.authorHalsall, D.en
dc.contributor.authorBurling, K.en
dc.contributor.authorMacguire, G.en
dc.contributor.authorWright, N.en
dc.contributor.authorCox, T. M.en
dc.contributor.authorMeikle, Peter Johnen
dc.contributor.authorDeegan, P. B.en
dc.date.issued2005en
dc.identifier.citationJournal of Inherited Metabolic Disease, 2005; 28:21-33en
dc.identifier.issn0141-8955en
dc.identifier.urihttp://hdl.handle.net/2440/17331-
dc.language.isoenen
dc.publisherKluwer Academic Publen
dc.titleMonitoring enzyme replacement therapy in Fabry disease - Role of urine globotriaosylceramideen
dc.typeJournal articleen
dc.contributor.schoolSchool of Paediatrics and Reproductive Health : Paediatricsen
dc.identifier.doi10.1007/s10545-005-4415-xen
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.